Perkins Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $924K | Sell |
8,333
-2,000
| -19% | -$222K | 0.93% | 36 |
|
|
2025
Q1 | $1.16M | Sell |
10,333
-500
| -5% | -$56K | 1.22% | 23 |
|
|
2024
Q4 | $1M | Sell |
10,833
-100
| -0.9% | -$9.24K | 0.89% | 39 |
|
|
2024
Q3 | $917K | Sell |
10,933
-1,500
| -12% | -$126K | 0.86% | 38 |
|
|
2024
Q2 | $853K | Sell |
12,433
-500
| -4% | -$34.3K | 0.8% | 40 |
|
|
2024
Q1 | $947K | Sell |
12,933
-50
| -0.4% | -$3.66K | 0.79% | 41 |
|
|
2023
Q4 | $1.05M | Sell |
12,983
-600
| -4% | -$48.6K | 0.9% | 39 |
|
|
2023
Q3 | $1.02M | Sell |
13,583
-34
| -0.2% | -$2.55K | 1.01% | 33 |
|
|
2023
Q2 | $1.05M | Hold |
13,617
| – | – | 0.91% | 38 |
|
|
2023
Q1 | $1.13M | Sell |
13,617
-200
| -1% | -$16.6K | 1.07% | 36 |
|
|
2022
Q4 | $1.19M | Sell |
13,817
-500
| -3% | -$42.9K | 1.25% | 29 |
|
|
2022
Q3 | $883K | Sell |
14,317
-1,300
| -8% | -$80.2K | 0.99% | 34 |
|
|
2022
Q2 | $965K | Sell |
15,617
-150
| -1% | -$9.27K | 1% | 37 |
|
|
2022
Q1 | $937K | Hold |
15,767
| – | – | 0.77% | 50 |
|
|
2021
Q4 | $1.15M | Sell |
15,767
-533
| -3% | -$38.7K | 0.77% | 47 |
|
|
2021
Q3 | $1.14M | Buy |
16,300
+900
| +6% | +$62.9K | 0.71% | 44 |
|
|
2021
Q2 | $1.06M | Buy |
15,400
+3,100
| +25% | +$213K | 0.6% | 50 |
|
|
2021
Q1 | $795K | Buy |
12,300
+200
| +2% | +$12.9K | 0.46% | 60 |
|
|
2020
Q4 | $705K | Buy |
12,100
+1,200
| +11% | +$69.9K | 0.46% | 56 |
|
|
2020
Q3 | $689K | Buy |
+10,900
| New | +$689K | 0.63% | 49 |
|
|
2020
Q1 | $792K | Buy |
+10,600
| New | +$792K | 0.96% | 39 |
|